Also found in: Medical.
NOS2Nitric Oxide Synthase 2
References in periodicals archive ?
Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: Common interferon signature but distinct NOS2 expression.
Although the expression of NOS2 and COX-2 were not evaluated in this study, the possibility of vitexin acting via inhibition of the expressions of these two potential targets for anti-inflammatory therapeutics cannot be ruled out.
The results of the present study showed that radio-attenuated live vaccine may help the animals to recover from T cell anergy, induce NOS2 and suppress TGF-[beta] gene expression.
And, they rarely mentioned about NOS1 Tentativeness, NOS2 Empirical basis, NOS4 Creativity, and NOS5 Socio-cultural embeddedness.
NOS 1 and NOS3 may themselves be induced under certain conditions (such as pregnancy) [15] and NOS2 is expressed constantly in certain sites (such as basal skin keratinocytes and salivary duct cells).
While the mechanism(s) by which apoE modify systemic and CNS inflammatory responses remain poorly defined, insight may be found in recent studies demonstrating that microglia derived from APOE4TR mice have altered cell morphology, increased NO production (accompanied by increased NOS2 mRNA levels), and enhanced cytokine production (TNF[alpha], IL-6, IL12) compared to microglia derived from APOE3TR mice (39).
The mechanisms of bacterial growth restriction seem clearly related to INF[gamma] production, but the role of NOS2 (iNOS) in this process is unresolved.
Third, using a candidate-gene approach based on a literature search for air pollution associated genes we investigated separately a set of 739 CpGs in 38 antioxidant and inflammatory genes (TGFB1, ARG1, ARG2, GSTM1, GSTP1, NQO1, SOD2, GPX1, HMOX-1, CAT, GSTT1, EPHX1, NOS2, TNF, NFE2L2, GSS, GPX7, GPX2, GSTZ1, ALB, SRXN1, NOX5, ALOX12, NCF2, AOX1, MPV17, SIRT2, MBL2, OXSR1, OXR1, NUDT1, DUOX2, EPX, PXDNL, PXDN, MPO, LPO, TPO) (Carlsten and Melen 2012; Chen et al.
La NOS2 y la ARGl producidas por las CMS pueden actuar individual o sinergicamente en la regulacion negativa de la funcion de los linfocitos T (27).